Oncologist is found guilty of misconduct after 27 year old patient dies in trialBMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e6352 (Published 20 September 2012) Cite this as: BMJ 2012;345:e6352
- Clare Dyer
A consultant described as “the father of urological oncology” in the UK has been found guilty of misconduct over his role as principal investigator in a clinical trial at University College London Hospital, in which a 27 year old patient died.
But Stephen Harland, the hospital, and research bodies had all learnt lessons that would make trials for cancer patients safer, and the consultant’s fitness to practise was not impaired, the Medical Practitioners Tribunal Service (MPTS) panel held.
Gary Foster, a graphic designer who had been told he had a 60% chance of survival, was taking part in a multicentre trial called TE23 funded by the Medical Research …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial